Xiaolan Lu
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 detection and testing
- SARS-CoV-2 and COVID-19 Research
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Epidemiology 10
- Liver Disease Diagnosis and Treatment 9
-
- Alcohol Consumption and Health Effects 3
- Co-authors
- Qin Du (7 shared papers)Xiaolan Guo (6 shared papers)Qiang Wang (6 shared papers)Guoyuan Zhang (4 shared papers)Bing Zhang (1 shared paper)Fang Li (1 shared paper)Qiang Ma (1 shared paper)Zhiming Tang (1 shared paper)
- Journals
- Scientific Reports (4 papers)World Journal of Gastroenterology (2 papers)Digestive Diseases and Sciences (1 paper)Clinica Chimica Acta (1 paper)Clinical and Experimental Pharmacology and Physiology (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaolan Lu
31 papers receiving 494 citations
Peers
Comparison fields: 5 of 63
- Infectious Diseases 114
- Hepatology 47
- Pathology and Forensic Medicine 77
- Nephrology 30
- Cancer Research 32
Countries citing papers authored by Xiaolan Lu
This map shows the geographic impact of Xiaolan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Lu more than expected).
Fields of papers citing papers by Xiaolan Lu
This network shows the impact of papers produced by Xiaolan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Lu. The network helps show where Xiaolan Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaolan Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 103 | |
| 2 | 2019 | 57 | |
| 3 | 2004 | 54 | |
| 4 | 2016 | 34 | |
| 5 | 2019 | 32 | |
| 6 | 2016 | 27 | |
| 7 | 2017 | 24 | |
| 8 | 2019 | 21 | |
| 9 | 2023 | 21 | |
| 10 | 2015 | 19 | |
| 11 | 2019 | 19 | |
| 12 | 2019 | 19 | |
| 13 | 2020 | 18 | |
| 14 | 2003 | 7 | |
| 15 | 2018 | 7 | |
| 16 | 2008 | 6 | |
| 17 | 2015 | 5 | |
| 18 | 2016 | 5 | |
| 19 | [Analysis of dangerous factors for alcoholic liver disease]. | 2004 | 4 |
| 20 | 2009 | 4 |
About Xiaolan Lu
Xiaolan Lu is a scholar working on Epidemiology, Pathology and Forensic Medicine, Hepatology, Infectious Diseases and Physiology, having authored 33 papers that have together received 510 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (9 papers), Clinical Laboratory Practices and Quality Control (3 papers), Alcohol Consumption and Health Effects (3 papers), Inflammatory mediators and NSAID effects (2 papers), Gastrointestinal motility and disorders (2 papers), Gut microbiota and health (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and SARS-CoV-2 detection and testing (2 papers). The work is most often cited by research in Infectious Diseases (114 citations), Hepatology (47 citations), Pathology and Forensic Medicine (77 citations), Nephrology (30 citations) and Cancer Research (32 citations). Xiaolan Lu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Qin Du, Xiaolan Guo, Qiang Wang, Guoyuan Zhang, Bing Zhang, Fang Li, Qiang Ma, Zhiming Tang, Dongsheng Wang and Guoyuan Zhang. Their work appears in journals such as Scientific Reports, World Journal of Gastroenterology, Digestive Diseases and Sciences, Clinica Chimica Acta and Clinical and Experimental Pharmacology and Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.